About NeoVista, Inc.

Upcoming Events

ASRS

Vancouver, British Columbia

August 28 - September 1

EURETINA/ESCRS

Paris, France

September 2-5

Retina Society

San Francisco, California

September 23 - 26

EVRS

Seville, Spain

September 25 - 28

AAO

Chicago, Illinois

October 16-19

Congress of German Ophthalmic Surgeons (DOC)

Hamburg, Germany

October 21-24

NeoVista News

February 2010

Good Health article: Surgeons stuck a needle in my eye and now I can see again. - (PDF, 287k)


November 2009

NeoVista®, Inc. Announces the Launch of VIDION® ANV® Therapy System in UK for Treating Wet Age-Related Macular Degeneration - (PDF, 25k)


NeoVista®, Inc. Announces First Neovascular AMD Patients Treated with VIDION® ANV® Therapy System in Europe Following Commercialization - (PDF, 87k)


NeoVista® Inc. Announces the Appointment of Jeffrey Nau to Position of Vice President of Medical and Clinical Affairs - (PDF, 13k)

October 2009

NeoVista®, Announces Initial VIDION® Shipments - (PDF, 89k)


NeoVista®, Inc. Announces Validation of Radiation Source Technology - (PDF, 22k)


NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age-Related Macular Degeneration - (PDF, 22k)


NeoVista®, Inc. Completes Enrollment in Pivotal CABERNET Study - (PDF, 18k)


NeoVista Presents 24-month Visual Acuity Data Outcomes of Novel Therapy for the Treatment of Neovascular Age-Related Macular Degeneration - (PDF, 23k)


Epimacular Brachytherapy for the Treatment of Neovascular AMD - NVI-111 24 Month VA Outcomes
(PDF, 18k)

August 2009

NeoVista®, Inc. Receives CE Mark Approval for VIDION® ANV® Therapy System
(PDF, 18k)

March 2009

NeoVista, Inc. Closes $18 million Series "D" Preferred Venture Financing Round
(PDF, 68k)

December 2008

FDA Grants NeoVista's Request to Utilize Novel Wet AMD Treatment in Compassionate Case
(PDF, 40k)

October 2008

NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy
(PDF, 40k)

September 2008

NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
(PDF, 42k)


NeoVista Appears on ABC7 KGO in San Francisco
(3:30 video)

May 2008

Novel Sight Saving Device in Trials at King's College Hospital, London
(PDF, 56k)

April 2008

FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
(PDF, 39k)


NeoVista Receives CE Mark Approval to Distribute Wet AMD Device in Europe
(PDF, 43k)

March 2008

NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
(PDF, 42k)

February 2008

NeoVista Presents a Revolutionary New Treatment for Wet Age-related Macular Degeneration
(PDF, 19k)

November 2007

First European Patient Treated in CABERNET Trial with Novel Treatment for Wet AMD
(PDF, 28k)


NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO
(PDF, 28k)

June 2007

NeoVista, Inc. Reports Commencement of CABERNET Clinical Trial for the Treatment of Age-Related Macular Degeneration
(PDF, 10k)

March 2007

NeoVista, Inc. Reports Positive 6 Month Concomitant Study Results on Wet AMD Therapy
(PDF, 69k)

January 2007

NeoVista, Inc. Reports Positive Study Results on Wet AMD Therapy
(PDF, 16k)

December 2006

NeoVista, Inc. Closes $41M Series "C" Financing Round
(Word doc, 25k)

Media Contact

 

Mr. Tony Moses
Vice President of Marketing & Sales
NeoVista, Inc.

47865 Fremont Blvd.
Fremont, CA 94538
Office: 510.933.7600
Fax: 510.933.7659
news@neovistainc.com



Media Content

 

Sky News - Radiation Beams Used To Restore Eyesight
Saturday November 21, 2009
Thomas Moore, health correspondent

 

German Television - Makula-Degeneration: Neue Behandlung rettet Augenlicht

 

The Epimacular Brachytherapy for the Treatment of CNV Due to AMD
(114M .wmv, please allow time for download)

 

Article: The NeoVista Investigational Device
(Retina Today)

 

News segment: NeoVista News Coverage in San Antonio

 

News segment: Investigational Device from NeoVista



NeoVista Fact Sheet

 

Fact Sheet as an Adobe Acrobat file. (76 KB in .pdf format).
(Note: Free download of Adobe Acrobat Reader from the Adobe Web Site.